Clinical Trials Logo

Clinical Trial Summary

The goal of this pivotal study is to demonstrate the safety and performance of the Cor TRICUSPID ECM (extracellular matrix) Valve (or Cor PEDIATRIC Tricuspid ECM Valve) for the surgical management of tricuspid valve disease and dysfunction in adult and pediatric patients. The main question(s) it aims to answer are: - whether the device may be implanted successfully and safely, and - whether the device effectively treats tricuspid valve disease and dysfunction through 12 months Participants will undergo: - preoperative evaluation - tricuspid valve replacement with the Cor TRICUSPID ECM Valve - postoperative evaluation, including at hospital discharge, 30 days, 6 months, and 12 months, and then annually thereafter through 5 years


Clinical Trial Description

CorMatrix Cardiovascular, Inc. has developed a device for heart valve replacement, the Cor TRICUSPID ECM Valve for adults and the Cor PEDIATRIC Tricuspid ECM Valve for pediatrics (collectively these devices will be referred to as the Cor TRICUSPID ECM Valve(s)), which can be implanted to replace dysfunctional tricuspid heart valves. The objective of this Pivotal Study is to collect safety and effectiveness data on surgical tricuspid valve replacement procedures using the Cor TRICUSPID ECM valve to support a Humanitarian Device Exemption (HDE) marketing application. Because the majority of tricuspid valve replacements (TVRs) (approximately 80%) are performed concomitantly with other cardiac operations, including replacements of mitral or aortic valves, it is anticipated that a portion of study subjects will require concomitant replacement or repair of a dysfunctional mitral or aortic valve, based on the clinical judgment of the investigator. Therefore, safety with the Cor TRICUSPID ECM Valve will be established by Procedural, Technical and Device Success. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05742906
Study type Interventional
Source CorMatrix Cardiovascular, Inc.
Contact Robert G Matheny, MD
Phone 404-276-7777
Email Rmatheny@Cormatrix.com
Status Recruiting
Phase N/A
Start date August 10, 2022
Completion date December 2024

See also
  Status Clinical Trial Phase
Recruiting NCT06196684 - Early Safety and Clinical Efficacy of Mitral Allograft in Tricuspid Surgery
Not yet recruiting NCT03278418 - Echo-Guided Tricuspid Valve Surgery Vs. Conservative Approach N/A
Terminated NCT03632967 - Early Feasibility Study of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System N/A
Active, not recruiting NCT05724225 - "Atriogenic Tricuspid Selected, Omics Profile, Multimodality Imaging and Clinical Outcomes"
Completed NCT02981953 - TRI-REPAIR: TrIcuspid Regurgitation RePAIr With CaRdioband Transcatheter System N/A
Completed NCT01444222 - Behaviour of Tricuspid Valve Regurgitation in Volume and/or Pressure Loaded Right Heart
Recruiting NCT04653428 - German Registry for Transcatheter Tricuspid Valve Interventions
Recruiting NCT02574650 - Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as TriAlign™. N/A
Completed NCT04945005 - Prevention of Pacemaker Lead Induced Tricuspid regurgitAtion by Transesophageal eCho guidEd Implantation Registry
Recruiting NCT03225612 - Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) N/A
Completed NCT01585779 - Contour 3D®/TriAd® Tricuspid Annuloplasty Ring Post-Market Clinical Trial N/A
Withdrawn NCT03166488 - MRE Evaluation of Liver Stiffness After Tricuspid Valvular Repair N/A
Completed NCT03604484 - Prophylactic Tricuspid Annuloplasty During Mitral Valve Surgery N/A
Completed NCT01537458 - Long-term Outcome After Isolated Tricuspid Valve Repair
Recruiting NCT05913908 - EFS of the DUO System for Tricuspid Regurgitation (TANDEM II) N/A
Recruiting NCT04436653 - THE TRAVEL TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve N/A
Completed NCT01334801 - Biomarkers in Aortic Stenosis - B.A.S.S.
Recruiting NCT04735003 - Transcatheter Interventions for Tricuspid Insufficiency in Italy
Recruiting NCT02314897 - Left Ventricular Pacing to Prevent Iatrogenic TR Pilot Study N/A
Completed NCT01532921 - EASE TRICUSPID Expertise-based Assessment Study on Clinical Efficacy of Contour 3D® in TRICUSPID Valve Annuloplasty